Biotech Biosion Today Presented Key Phase 2 POC Clinical Study Results for Bosakitug, an Anti-TSLP mAb, in Atopic Dermatitis Subjects at the Revolutionizing Atopic Dermatitis Conference June 18, 2024
Biotech Proteomics Market to Reach $161.9 billion, Globally, by 2035 at 14.2% CAGR: Allied Market Research June 18, 2024
Biotech Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets May 3, 2024
Search
Biotech
June 18, 2024
June 18, 2024
June 18, 2024
May 3, 2024
May 3, 2024
April 24, 2024
April 24, 2024
April 24, 2024
